861 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Bronchogenic" (861 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Recruiting Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Conditions: Non Small Cell Lung Cancer;   Small Cell Lung Cancer;   Thymoma;   Thymus Neoplasms
Intervention: Radiation: Esophageal sparing IMRT
6 Unknown  Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: microarray analysis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: staining method
7 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
8 Recruiting Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Ipilimumab;   Radiation: Radiotherapy (IMRT)
9 Unknown  Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments
Condition: Non Small-cell Lung Cancer
Intervention: Procedure: Dual-agent therapy or docetaxel alone or best supportive care
10 Recruiting Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Liver Cancer;   Adrenal Cancer
Intervention: Radiation: stereotactic body radiation therapy
11 Recruiting Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
Condition: Carcinoma, Small Cell
Intervention: Drug: Temozolomide
12 Recruiting A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Adenocarcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Metformin
13 Unknown  Stereotactic Radiosurgery in Treating Patients Undergoing Chemotherapy and Radiation Therapy For Stage III Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Procedure: quality-of-life assessment;   Radiation: radiation therapy;   Radiation: stereotactic radiosurgery
14 Recruiting Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Unresectable
Intervention:
15 Recruiting An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: PF-02341066
16 Recruiting Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
Conditions: Non-small Cell Lung Cancer Metastatic;   Non-small Cell Lung Cancer Stage IIIB
Interventions: Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Cisplatin
17 Recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: hypofractionated radiation therapy;   Other: laboratory biomarker analysis;   Radiation: image-guided radiation therapy;   Drug: carboplatin;   Drug: paclitaxel;   Radiation: stereotactic body radiation therapy
18 Recruiting A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer
Condition: Lung Cancer
Interventions: Other: Standard dosing method arm: Cisplatin (chemotherapy) dosing based on body surface area;   Other: Experimental dosing method arm: Cisplatin (chemotherapy) dosing based on individual lean body mass
19 Recruiting Study of Use of CTC in NSCLC
Conditions: Non Small Cell Lung Cancer;   Chronic Obstructive Pulmonary Disease
Intervention:
20 Recruiting TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer
Condition: Carcinoma, Non Small Cell Lung
Interventions: Drug: Taxotere;   Drug: Pemetrexed

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years